Walleye Capital
IONS icon

Walleye Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Walleye Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95M Buy
65,949
+65,624
+20,192% +$5.18M 0.02% 809
2025
Q4 		$25.7K Buy
+325
New +$24.5K ﹤0.01% 4215
2025
Q3 		– Sell
-66,482
Closed -$3.25M – 4798
2025
Q2 		$2.63M Sell
66,482
-28,508
-30% -$933K 0.01% 1310
2025
Q1 		$2.87M Buy
94,990
+78,735
+484% +$2.58M 0.01% 1178
2024
Q4 		$568K Sell
16,255
-107,861
-87% -$4.03M ﹤0.01% 2880
2024
Q3 		$4.97M Buy
124,116
+26,245
+27% +$1.22M 0.01% 1170
2024
Q2 		$4.66M Buy
97,871
+8,741
+10% +$359K 0.01% 1343
2024
Q1 		$3.86M Buy
+89,130
New +$4.25M 0.01% 1495
2023
Q2 		– Sell
-2,240
Closed -$86.1K – 4576
2023
Q1 		$80.1K Sell
2,240
-23,814
-91% -$894K ﹤0.01% 3041
2022
Q4 		$984K Sell
26,054
-59,909
-70% -$2.52M 0.02% 1011
2022
Q3 		$3.8M Buy
85,963
+79,594
+1,250% +$3.35M 0.07% 292
2022
Q2 		$236K Buy
+6,369
New +$240K 0.01% 1440
2021
Q4 		– Sell
-15,470
Closed -$519 – 2199
2021
Q3 		$519 Buy
+15,470
New +$583K 0.01% 774
2019
Q3 		– Sell
-170
Closed -$11.1K – 2053
2019
Q2 		$11K Sell
170
-1,490
-90% -$105K ﹤0.01% 1584
2019
Q1 		$135K Buy
+1,660
New +$107K 0.02% 920

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's IONS Position: Q1 2026 in Review

Walleye Capital increased its Ionis Pharmaceuticals (IONS) stake by 20,192% in Q1 2026, buying an estimated $5.18M and bringing the position to 65,949 shares worth $4.95M. The position accounts for 0.02% of the portfolio, ranked #809.

Walleye Capital first reported a position in IONS in Q1 2019 and has held it in 15 quarters since. The position peaked at $4.97M in Q3 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Walleye Capital held 65,949 shares of Ionis Pharmaceuticals worth $4.95M as of Q1 2026.
  • Walleye Capital bought 65,624 Ionis Pharmaceuticals shares in Q1 2026, an estimated $5.18M.
  • Ionis Pharmaceuticals made up 0.02% of Walleye Capital's portfolio in Q1 2026, its #809 holding.
  • Walleye Capital first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
  • Walleye Capital's Ionis Pharmaceuticals position peaked at $4.97M in Q3 2024.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.